Managers / Q4 2023 · view latest →
Global Alpha Capital Management Ltd.
CIK 0001584691 · 1800 MCGILL COLLEGE AVENUE, SUITE 1300, MONTREAL, A8, H3A 3J6 · 514-490-2779
Summary
Global Alpha Capital Management Ltd. reported $1.2B in U.S.-listed holdings across 54 positions for Q4 2023.
Its largest position, HNM, represents 14.3% of the portfolio.
Compared with Q3 2023, the fund opened 21 new positions and exited 3.
Portfolio Metrics
Methodology: turnover is min(value bought, value sold) ÷ average reported value across the two quarters — value-based, so market moves inflate it slightly versus a share-based measure. Concentration and largest position are shares of the filing’s total reported value, options excluded. New/exited counts compare against the prior filed quarter. All figures derive solely from the fund’s 13F filings.
Reported Value by Quarter
Portfolio Composition
- Common Stock · 95.1% · $1.2B
- REIT · 4.0% · $50M
- Other · 0.9% · $11M
Quarter-over-Quarter Changes full breakdown →
vs Q3 2023 (amended baseline)
| Issuer | Move | Share Δ | Shares now | Value Δ | Value now |
|---|---|---|---|---|---|
| CWSTCASELLA WASTE SYS INC | NEW | +209.7K | 209.7K | +$18M | $18M |
| AAONAAON INC | NEW | +157.0K | 157.0K | +$12M | $12M |
| EVREVERCORE INC | NEW | +66.3K | 66.3K | +$11M | $11M |
| PCRXPACIRA BIOSCIENCES INC | NEW | +72.5K | 72.5K | +$2M | $2M |
| LRNSTRIDE INC | NEW | +35.8K | 35.8K | +$2M | $2M |
| BCPCBALCHEM CORP | NEW | +14.2K | 14.2K | +$2M | $2M |
| VMIVALMONT INDS INC | NEW | +8.8K | 8.8K | +$2M | $2M |
| TDOCTELADOC HEALTH INC | NEW | +93.7K | 93.7K | +$2M | $2M |
Value changes conflate price moves with buying and selling — share changes are the real signal. Share counts are not split-adjusted.
Holdings — Q4 2023
Filing History
| Quarter | Reported Value | Positions | Filed | Type | Links |
|---|---|---|---|---|---|
| Q1 2026 | $1.7B | 54 | May 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q4 2025 | $1.6B | 56 | Feb 11, 2026 | 13F-HR | changes · EDGAR ↗ |
| Q3 2025 | $1.7B | 56 | Nov 13, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q2 2025 | $1.6B | 56 | Aug 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q1 2025 | $1.4B | 58 | May 12, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q4 2024 | $1.4B | 56 | Feb 7, 2025 | 13F-HR | changes · EDGAR ↗ |
| Q3 2024 | $1.5B | 57 | Nov 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q2 2024 | $1.4B | 57 | Aug 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q1 2024 | $1.3B | 55 | May 8, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q4 2023 | $1.2B | 54 | Feb 9, 2024 | 13F-HR | changes · EDGAR ↗ |
| Q3 2023 | $996M | 36 | Nov 13, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q2 2023 | $1.1B | 33 | Aug 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q1 2023 | $1.1B | 34 | May 9, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q4 2022 | $1.0B | 34 | Feb 10, 2023 | 13F-HR | changes · EDGAR ↗ |
| Q3 2022 | $1.0B | 35 | Nov 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q2 2022 | $927M | 35 | Aug 5, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q1 2022 | $1.2B | 35 | May 12, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q4 2021 | $1.0B | 34 | Feb 10, 2022 | 13F-HR | changes · EDGAR ↗ |
| Q3 2021 | $900M | 35 | Nov 12, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q2 2021 | $922M | 34 | Aug 2, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q1 2021 | $855M | 34 | Apr 30, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q4 2020 | $816M | 35 | Feb 10, 2021 | 13F-HR | changes · EDGAR ↗ |
| Q3 2020 | $651M | 36 | Nov 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q2 2020 | $630M | 34 | Aug 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q1 2020 | $554M | 40 | May 13, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q4 2019 | $674M | 37 | Feb 12, 2020 | 13F-HR | changes · EDGAR ↗ |
| Q3 2019 | $578M | 37 | Nov 13, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q2 2019 | $575M | 38 | Aug 7, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q1 2019 | $524M | 37 | May 8, 2019 | 13F-HR | changes · EDGAR ↗ |
| Q4 2018 | $387M | 34 | Feb 11, 2019 | 13F-HR | changes · EDGAR ↗ |
13F filings are due up to 45 days after quarter end, so holdings shown here lag the fund’s current book. Source: original SEC filing on EDGAR ↗.